在APOE ε4,认知衰退和痴呆症之间的关系中的性别变化
Eleanor M Kerr1, Jennifer A Ailshire2, Eileen Crimmins2
1School of Public Policy University of Maryland College Park Maryland USA.
Alzheimer's & dementia (Amsterdam, Netherlands)
|May 5, 2025
概括
无脂蛋白E (APOE) ε4基因与认知衰退和痴呆症有关,但这种关联在白人或黑人成年人中没有性别差异. 这一发现挑战了以前关于痴呆风险的性别特异性影响的假设.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 无脂蛋白E (APOE) ε4等位基因是已知的认知衰退和痴呆的遗传风险因素.
- 以前的研究表明,APOE ε4对认知衰老的影响可能存在性别差异.
研究的目的:
- 调查APOE ε4与认知衰退或痴呆症发病之间的关联是否因性别而异.
- 为了检查非西班牙裔白人和黑人人口之间的这些关系.
主要方法:
- 利用了来自健康和退休研究的数据.
- 采用种族分层线性混合模型用于认知衰退和Cox比例风险模型用于痴呆发病.
- 在统计模型中使用交互术语评估性别差异.
主要成果:
- 在白人成年人中,APOE ε4与更快的认知衰退和更早的痴呆发作有关.
- 在黑人成年人中,APOE ε4与更快的认知衰退有关.
- 在APOE ε4与认知衰退或痴呆症发病之间的关系中,在任何种族群体中都没有观察到显著的性别差异.
结论:
- 该研究的结果不支持假设女性APOE ε4携带者与男性相比经历更快速的认知衰退或更早的痴呆发作.
- 强调在遗传研究中使用概率样本的重要性,以减轻潜在的偏见.
- 表明APOE ε4对认知衰老的影响可能与性别相似.
更多相关视频
09:38Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
相关概念视频
Genetic Lingo
Overview
Sex Linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
